Black Diamond Therapeutics, Inc.
USD1.75
+0.04 (+2.34%)
CEO
Mark A. Velleca
IPO Date
2020-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.74
Prev. Close
$1.71
Day Low
$1.70
Day High
$1.77
52W Low
$1.60
52W High
$4.94
Market Cap
$0.10B
Volume
1.15M
| -1.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -70.6% | -52.0% | 0.22 | 6.82 | -1.5 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -78.8% | -58.3% | 0.24 | 8.37 | -0.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -64.1% | -50.7% | 0.15 | 9.12 | -1.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -21.9% | -20.4% | 0.03 | 22.48 | -15.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 74.8% | -22.3% | 0.00 | 32.02 | -40.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 57.5% | -17.2% | -3.91 | 20.07 | -61.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 68.9% | -57.4% | -1.87 | 3.55 | -61.7 |
| -2.3 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -6.7% | -5.4% | 0.13 | 8.94 | -6.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -8.0% | -6.3% | 0.16 | 8.73 | -3.3 |
| 31 Mar 2025 | Q1 | 100.0% | 80.8% | 40.0% | 32.1% | 0.15 | 9.24 | 0.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -19.2% | -13.0% | 0.27 | 4.92 | -1.9 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -16.0% | -11.3% | 0.24 | 5.55 | -4.0 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -17.9% | -13.3% | 0.21 | 6.87 | -3.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -17.5% | -12.8% | 0.24 | 7.05 | -3.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -16.6% | -12.2% | 0.22 | 6.82 | -1.7 |